Barclays’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66K | Sell |
45,823
-61,697
| -57% | -$88.9K | ﹤0.01% | 3905 |
|
|
2025
Q1 | $172K | Sell |
107,520
-14,845
| -12% | -$23.7K | ﹤0.01% | 3422 |
|
|
2024
Q4 | $441K | Sell |
122,365
-121,092
| -50% | -$436K | ﹤0.01% | 3123 |
|
|
2024
Q3 | $1.39M | Buy |
243,457
+67,546
| +38% | +$385K | ﹤0.01% | 2418 |
|
|
2024
Q2 | $812K | Buy |
175,911
+122,818
| +231% | +$567K | ﹤0.01% | 2239 |
|
|
2024
Q1 | $434K | Buy |
53,093
+9,478
| +22% | +$77.5K | ﹤0.01% | 2916 |
|
|
2023
Q4 | $247K | Buy |
43,615
+1
| +0% | +$6 | ﹤0.01% | 3419 |
|
|
2023
Q3 | $81K | Buy |
43,614
+10,246
| +31% | +$19K | ﹤0.01% | 3401 |
|
|
2023
Q2 | $92K | Sell |
33,368
-13,995
| -30% | -$38.6K | ﹤0.01% | 3430 |
|
|
2023
Q1 | $148K | Sell |
47,363
-56,285
| -54% | -$176K | ﹤0.01% | 3320 |
|
|
2022
Q4 | $611K | Buy |
103,648
+28,408
| +38% | +$167K | ﹤0.01% | 2467 |
|
|
2022
Q3 | $660K | Buy |
75,240
+71,244
| +1,783% | +$625K | ﹤0.01% | 2403 |
|
|
2022
Q2 | $30K | Sell |
3,996
-23,647
| -86% | -$178K | ﹤0.01% | 3935 |
|
|
2022
Q1 | $670K | Buy |
+27,643
| New | +$670K | ﹤0.01% | 2598 |
|